| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 481.53B | 438.32B | 442.78B | 431.20B | 388.36B |
| Gross Profit | 97.94B | 82.64B | 81.28B | 85.25B | 78.76B |
| EBITDA | 48.81B | 39.11B | 39.89B | 50.35B | 48.23B |
| Net Income | 29.04B | 14.90B | 15.82B | 27.21B | 22.55B |
Balance Sheet | |||||
| Total Assets | 493.73B | 463.11B | 476.53B | 446.84B | 434.19B |
| Cash, Cash Equivalents and Short-Term Investments | 50.18B | 47.43B | 46.64B | 43.59B | 52.12B |
| Total Debt | 114.03B | 104.30B | 101.14B | 114.32B | 117.83B |
| Total Liabilities | 233.82B | 228.09B | 250.12B | 255.80B | 273.27B |
| Stockholders Equity | 249.78B | 225.54B | 217.19B | 182.83B | 153.41B |
Cash Flow | |||||
| Free Cash Flow | -2.81B | 26.80B | 15.25B | 12.29B | 14.95B |
| Operating Cash Flow | 19.51B | 43.85B | 39.86B | 23.91B | 24.25B |
| Investing Cash Flow | -6.62B | -34.13B | -23.50B | -13.52B | -10.87B |
| Financing Cash Flow | -12.32B | -9.10B | -15.03B | -20.18B | -32.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥715.90B | 26.07 | ― | 2.60% | 1.89% | -39.75% | |
74 Outperform | ¥554.02B | 9.48 | 8.58% | 2.62% | 8.21% | 72.79% | |
66 Neutral | ¥672.48B | 57.58 | 3.35% | 3.18% | 2.15% | -6.81% | |
64 Neutral | ¥203.31B | 4.90 | 13.11% | 2.87% | 9.86% | 119.04% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.68T | 10.27 | 8.34% | 2.03% | 4.53% | 65.12% | |
55 Neutral | ¥521.84B | 490.48 | ― | 1.93% | <0.01% | -83.75% |